Clinical Trials Browser

Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasms, Cholangiocarcinoma, Klatskin Tumor, Neoplasm, Residual

NCT07326189 2026-01-16

PHAE-PHCC

Phase NA Not yet recruiting

33 enrolled

Gastrointestinal

Klatskin Tumor

NCT07311798 2025-12-31

Impact of Vascular Resection on Survival and Postoperative Outcomes in Patients With Hilar Cholangiocarcinoma: A Retrospective Study

Not yet recruiting

300 enrolled

Gastrointestinal

Klatskin Tumor

NCT03104569 2025-12-26

Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma

Phase NA Not yet recruiting

100 enrolled

Gastrointestinal

Cholangitis, Klatskin Tumor

NCT07161869 2025-09-09

POELH-III

Not yet recruiting

250 enrolled

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Biliary Tract Neoplasms, Common Bile Duct Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT07149558 2025-09-02

Volume-Restricted Resection for Perihilar Cholangiocarcinoma

Not yet recruiting

300 enrolled

Gastrointestinal

Klatskin Tumor

NCT07030140 2025-06-22

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Phase 2 Not yet recruiting

38 enrolled

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT06923475 2025-04-11

NEODISCO

Phase 2/3 Not yet recruiting

150 enrolled

Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

NCT06658587 2024-10-26

A Novel Serological Risk Model for Early Non-invasive Diagnosis of Cholangiocarcinoma

Not yet recruiting

60 enrolled

Gastrointestinal

Disease, Cholangiocarcinoma, Klatskin Tumor

NCT06175845 2023-12-19

ACTICCA-2

Phase NA Not yet recruiting

130 enrolled

Gastrointestinal

Bile Duct Neoplasms, Bites and Stings, Cholangitis, Liver Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Clinical Trials

TRACE-BTC

PHAE-PHCC

Impact of Vascular Resection on Survival and Postoperative Outcomes in Patients With Hilar Cholangiocarcinoma: A Retrospective Study

Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma

POELH-III

Volume-Restricted Resection for Perihilar Cholangiocarcinoma

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

NEODISCO

A Novel Serological Risk Model for Early Non-invasive Diagnosis of Cholangiocarcinoma

ACTICCA-2